{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:47:12Z","timestamp":1768517232641,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T00:00:00Z","timestamp":1222473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s10549-008-0190-3","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T18:54:48Z","timestamp":1222455288000},"page":"497-504","source":"Crossref","is-referenced-by-count":27,"title":["Founder mutations account for the majority of BRCA1-attributable hereditary breast\/ovarian cancer cases in a population from Tuscany, Central Italy"],"prefix":"10.1007","volume":"117","author":[{"given":"Laura","family":"Papi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Laura","family":"Putignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Congregati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Sera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doralba","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Falchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Rosselli Del","family":"Turco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ottini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Genuardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,27]]},"reference":[{"issue":"Suppl 6","key":"190_CR1","doi-asserted-by":"crossref","first-page":"vi93","DOI":"10.1093\/annonc\/mdm234","volume":"18","author":"R Ferla","year":"2007","unstructured":"Ferla R, Cal\u00f2 V, Cascio S et al (2007) Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 18(Suppl 6):vi93\u2013vi98. doi: 10.1093\/annonc\/mdm234","journal-title":"Ann Oncol"},{"key":"190_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.1167","volume":"18","author":"F Baudi","year":"2001","unstructured":"Baudi F, Quaresima B, Grandinetti C et al (2001) Evidence of a founder mutation of BRCA1 in a highly homogeneous population from Southern Italy with breast\/ovarian cancer. Hum Mutat 18:163\u2013164. doi: 10.1002\/humu.1167","journal-title":"Hum Mutat"},{"key":"190_CR3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1469-1809.2007.00420.x","volume":"72","author":"F Marroni","year":"2008","unstructured":"Marroni F, Cipollini G, Peissel B et al (2008) Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis. Ann Hum Genet 72:310\u2013318. doi: 10.1111\/j.1469-1809.2007.00420.x","journal-title":"Ann Hum Genet"},{"key":"190_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.2007.13.2118","volume":"26","author":"S Malacrida","year":"2008","unstructured":"Malacrida S, Agata S, Callegaro M et al (2008) BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy. J Clin Oncol 26:26\u201331. doi: 10.1200\/JCO.2007.13.2118","journal-title":"J Clin Oncol"},{"key":"190_CR5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/bjoc.1999.0963","volume":"82","author":"M Pisano","year":"2000","unstructured":"Pisano M, Cossu A, Persico I et al (2000) Identification of a founder BRCA2 mutation in Sardinia. Br J Cancer 82:553\u2013559. doi: 10.1054\/bjoc.1999.0963","journal-title":"Br J Cancer"},{"key":"190_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10689-006-9107-7","volume":"6","author":"M Monne","year":"2007","unstructured":"Monne M, Piras G, Fancello P et al (2007) Identification of a founder BRCA2 mutation in Sardinian breast cancer families. Fam Cancer 6:73\u201379. doi: 10.1007\/s10689-006-9107-7","journal-title":"Fam Cancer"},{"key":"190_CR7","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701\u20132712. doi: 10.1200\/JCO.2002.05.121","journal-title":"J Clin Oncol"},{"key":"190_CR8","author":"L Ottini","year":"2008","unstructured":"Ottini L, Rizzolo P, Zanna I et\u00a0al (2008) BRCA1\/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in Central Italy. Breast Cancer Res Treat. doi: 10.1007\/s10549-008-0194-z","journal-title":"Breast Cancer Res Treat"},{"key":"190_CR9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/bioinformatics\/18.6.894","volume":"18","author":"JP Reeve","year":"2002","unstructured":"Reeve JP, Rannala B (2002) DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 18:894\u2013895. doi: 10.1093\/bioinformatics\/18.6.894","journal-title":"Bioinformatics"},{"key":"190_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/321279","volume":"69","author":"B Rannala","year":"2001","unstructured":"Rannala B, Reeve JP (2001) High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence. Am J Hum Genet 69:159\u2013178. doi: 10.1086\/321279","journal-title":"Am J Hum Genet"},{"key":"190_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.ejhg.5200704","volume":"9","author":"A Bergman","year":"2001","unstructured":"Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9:787\u2013793. doi: 10.1038\/sj.ejhg.5200704","journal-title":"Eur J Hum Genet"},{"key":"190_CR12","unstructured":"Beloch KJ (1995) Storia della popolazione d\u2019Italia. In: Del Panta L, Sonnino E (eds) Le Lettere, Firenze, pp xxxii, 695"},{"key":"190_CR13","first-page":"1457","volume":"57","author":"D Ford","year":"1995","unstructured":"Ford D, Easton DF, Peto J (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457\u20131462","journal-title":"Am J Hum Genet"},{"key":"190_CR14","first-page":"496","volume":"60","author":"AS Whittemore","year":"1997","unstructured":"Whittemore AS, Gong G, Itnyre J (1997) Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three US population-based case-control studies of ovarian cancer. Am J Hum Genet 60:496\u2013504","journal-title":"Am J Hum Genet"},{"key":"190_CR15","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694\u20131706","journal-title":"J Natl Cancer Inst"},{"key":"190_CR16","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.2078.13.12","volume":"13","author":"AS Whittemore","year":"2004","unstructured":"Whittemore AS, Gong G, John EM et al (2004) Prevalence of BRCA1 mutation carriers among US non-Hispanic whites. Cancer Epidemiol Biomarkers Prev 13:2078\u20132083","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"190_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","volume":"86","author":"AC Antoniou","year":"2002","unstructured":"Antoniou AC, Pharoah PD, McMullan G et al (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76\u201383. doi: 10.1038\/sj.bjc.6600008","journal-title":"Br J Cancer"},{"key":"190_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cancergencyto.2006.05.005","volume":"170","author":"F Bonatti","year":"2006","unstructured":"Bonatti F, Pepe C, Tancredi M et al (2006) RNA-based analysis of BRCA1 and BRCA2 gene alterations. Cancer Genet Cytogenet 170:93\u2013101. doi: 10.1016\/j.cancergencyto.2006.05.005","journal-title":"Cancer Genet Cytogenet"},{"key":"190_CR19","first-page":"342","volume":"63","author":"L Ottini","year":"2003","unstructured":"Ottini L, Masala G, D\u2019Amico C et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63:342\u2013347","journal-title":"Cancer Res"},{"key":"190_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.genom.1.1.225","volume":"1","author":"M Slatkin","year":"2000","unstructured":"Slatkin M, Rannala B (2000) Estimating allele age. Annu Rev Genomics Hum Genet 1:225\u2013249. doi: 10.1146\/annurev.genom.1.1.225","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"190_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","volume":"61","author":"DF Easton","year":"1997","unstructured":"Easton DF, Steele L, Fields P et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12\u201313. Am J Hum Genet 61:120\u2013128. doi: 10.1086\/513891","journal-title":"Am J Hum Genet"},{"key":"190_CR22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G et al (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99:1811\u20131814. doi: 10.1093\/jnci\/djm203","journal-title":"J Natl Cancer Inst"},{"key":"190_CR23","first-page":"313","volume":"60","author":"LS Friedman","year":"1997","unstructured":"Friedman LS, Gayther SA, Kurosaki T et al (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313\u2013319","journal-title":"Am J Hum Genet"},{"key":"190_CR24","first-page":"995","volume":"59","author":"B Csokay","year":"1997","unstructured":"Csokay B, Udvarhelyi N, Sulyok Z et al (1997) High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res 59:995\u2013998","journal-title":"Cancer Res"},{"key":"190_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-007-9153-9","volume":"7","author":"DG Evans","year":"2008","unstructured":"Evans DG, Bulman M, Young K et al (2008) BRCA1\/2 mutation analysis in male breast cancer families from North West England. Fam Cancer 7:113\u2013117. doi: 10.1007\/s10689-007-9153-9","journal-title":"Fam Cancer"},{"key":"190_CR26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"190_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-007-9729-y","volume":"110","author":"T Anagnostopoulos","year":"2008","unstructured":"Anagnostopoulos T, Pertesi M, Konstantopoulou I et al (2008) G1738R is a BRCA1 founder mutation in Greek breast\/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. Breast Cancer Res Treat 110:377\u2013385. doi: 10.1007\/s10549-007-9729-y","journal-title":"Breast Cancer Res Treat"},{"key":"190_CR28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.ejhg.5200529","volume":"8","author":"L Sarantaus","year":"2000","unstructured":"Sarantaus L, Huusko P, Eerola H et al (2000) Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet 8:757\u2013763. doi: 10.1038\/sj.ejhg.5200529","journal-title":"Eur J Hum Genet"},{"key":"190_CR29","first-page":"1041","volume":"60","author":"T Peelen","year":"1997","unstructured":"Peelen T, van Vliet M, Petrij-Bosch A et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041\u20131049","journal-title":"Am J Hum Genet"},{"key":"190_CR30","first-page":"271","volume":"58","author":"SL Neuhausen","year":"1996","unstructured":"Neuhausen SL, Mazoyer S, Friedman L et al (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271\u2013280","journal-title":"Am J Hum Genet"},{"key":"190_CR31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1200\/JCO.2006.06.9443","volume":"25","author":"PM Machado","year":"2007","unstructured":"Machado PM, Brand\u00e3o RD, Cavaco BM et al (2007) Screening for a BRCA2 rearrangement in high-risk breast\/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J Clin Oncol 25:2027\u20132034. doi: 10.1200\/JCO.2006.06.9443","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0190-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0190-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:34:47Z","timestamp":1684557287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0190-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,27]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0190-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,27]]}}}